|
US20030013772A1
(en)
*
|
2000-02-23 |
2003-01-16 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
US20050085555A1
(en)
*
|
1997-08-21 |
2005-04-21 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
US7312244B2
(en)
|
1999-04-30 |
2007-12-25 |
Cellgate, Inc. |
Polyamine analog-amino acid conjugates useful as anticancer agents
|
|
IL146126A0
(en)
|
1999-04-30 |
2002-07-25 |
Slil Biomedical Corp |
Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
|
|
DE60029944T2
(de)
*
|
1999-04-30 |
2007-04-05 |
Cellgate, Inc., Redwood City |
Polyamine und ihre therapeutische verwendung
|
|
US20030130356A1
(en)
*
|
2001-10-16 |
2003-07-10 |
Slil Biomedical Corporation |
Oligoamine compounds and derivatives thereof for cancer therapy
|
|
JP2004189714A
(ja)
*
|
2002-12-09 |
2004-07-08 |
Rasanen Tiina-Liisa |
すい臓炎の治療と予防ならびに肝臓再生機能の誘導のための薬剤
|
|
WO2007035703A1
(en)
|
2005-09-20 |
2007-03-29 |
Schering Corporation |
1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
FR2917971B1
(fr)
|
2007-06-28 |
2009-10-23 |
Engelhard Lyon Soc Par Actions |
Composition amincissante
|
|
US8153611B2
(en)
*
|
2007-06-28 |
2012-04-10 |
Basf Beauty Care Solutions France S.A.S. |
Use of sulfated oligosaccharides as slimming cosmetic ingredients
|
|
ES2616291T3
(es)
*
|
2007-06-28 |
2017-06-12 |
Basf Beauty Care Solutions France Sas |
Composición adelgazante
|
|
AU2008317057B8
(en)
|
2007-10-22 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Bicyclic Heterocycle Derivatives and their use as modulators of the activity of GPR119
|
|
AU2009249237A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
|
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
RU2392933C2
(ru)
*
|
2008-07-18 |
2010-06-27 |
Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) |
Средство, обладающее гиполипидемическими свойствами
|
|
EP2318388A2
(en)
|
2008-07-23 |
2011-05-11 |
Schering Corporation |
Tricyclic spirocycle derivatives and methods of use thereof
|
|
JP2012504630A
(ja)
|
2008-10-03 |
2012-02-23 |
シェーリング コーポレイション |
グルカゴン受容体アンタゴニストとしてのスピロイミダゾロン誘導体
|
|
AU2009303444A1
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Azine derivatives and methods of use thereof
|
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
|
EP2379547A1
(en)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
US20110245267A1
(en)
|
2008-12-19 |
2011-10-06 |
Schering Plough Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
|
WO2010071819A1
(en)
|
2008-12-19 |
2010-06-24 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
|
CA2747809A1
(en)
|
2008-12-23 |
2010-07-01 |
Joel M. Harris |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010075269A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010107768A1
(en)
|
2009-03-18 |
2010-09-23 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
|
WO2010114957A1
(en)
|
2009-04-03 |
2010-10-07 |
Schering Corporation |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
|
WO2010144664A1
(en)
|
2009-06-12 |
2010-12-16 |
Schering Corporation |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
|
EP2477498A4
(en)
|
2009-09-14 |
2013-02-27 |
Merck Sharp & Dohme |
INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE
|
|
US8759357B2
(en)
|
2009-10-08 |
2014-06-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (FABP)
|
|
WO2011053688A1
(en)
|
2009-10-29 |
2011-05-05 |
Schering Corporation |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
|
WO2011062889A1
(en)
|
2009-11-23 |
2011-05-26 |
Schering Corporation |
Pyrimidine ether derivatives and methods of use thereof
|
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
|
US9301929B2
(en)
|
2009-11-24 |
2016-04-05 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
|
WO2011113060A2
(en)
*
|
2010-03-12 |
2011-09-15 |
Trana Discovery, Inc. |
Antiviral compounds and methods of use thereof
|
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
ITMI20130555A1
(it)
*
|
2013-04-09 |
2014-10-10 |
Giuliani Spa |
Composizione farmaceutica o cosmetica per contrastare l¿invecchiamento della pelle attraverso un¿azione antiinfiammatoria
|
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|